<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Exp Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Mol. Med</journal-id>
<journal-title-group>
<journal-title>Experimental &amp; Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-3613</issn>
<issn pub-type="epub">2092-6413</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29628500</article-id>
<article-id pub-id-type="pmc">5938024</article-id>
<article-id pub-id-type="publisher-id">18</article-id>
<article-id pub-id-type="doi">10.1038/s12276-017-0018-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sang-Eun</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jung Ah</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chang</surname>
<given-names>Sunghoe</given-names>
</name>
<address>
<phone>+(82)2-740-8918</phone>
<email>sunghoe@snu.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution>Department of Physiology and Biomedical Sciences, </institution><institution>Seoul National University College of Medicine, </institution></institution-wrap>Seoul, 03080 South Korea </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution>Interdisciplinary Program in Neuroscience, College of Natural Sciences, </institution><institution>Seoul National University, </institution></institution-wrap>Seoul, 08826 South Korea </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution>Neuroscience Research Institute, </institution><institution>Seoul National University College of Medicine, </institution></institution-wrap>Seoul, 03080 South Korea </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>9</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>4</month>
<year>2018</year>
</pub-date>
<volume>50</volume>
<issue>4</issue>
<elocation-id>2</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Despite the complex genetic architecture, a broad spectrum of psychiatric disorders can still be caused by mutation(s) in the same gene. These disorders are interrelated with overlapping causative mechanisms including variations in the interaction among the risk-associated proteins that may give rise to the specific spectrum of each disorder. Additionally, multiple lines of evidence implicate an imbalance between excitatory and inhibitory neuronal activity (E/I imbalance) as the shared key etiology. Thus, understanding the molecular mechanisms underlying E/I imbalance provides essential insight into the etiology of these disorders. One important class of candidate risk genes is the postsynaptic scaffolding proteins, such as nArgBP2, SAPAP, and SHANK that regulate the actin cytoskeleton in dendritic spines of excitatory synapses. This review will cover and discuss recent studies that examined how these proteins, especially nArgBP2, are associated with psychiatric disorders. Next, we propose a possibility that variations in the interaction among these proteins in a specific brain region might contribute to the onset of diverse phenotypes of psychiatric disorders.</p>
</abstract>
<abstract abstract-type="LongSummary" id="Abs2">
<title>Psychiatric disorder: Interactions between post-synaptic proteins</title>
<p id="Par2">The assembly of scaffolding proteins, key regulators of many signaling pathways, found in the brain’s synapses underpin a diverse range of neuropsychiatric disorders. Sunghoe Chang and colleagues from Seoul National University, South Korea, review how these postsynaptic proteins regulate the cellular cytoskeleton in nerve cell protrusions to maintain the balance between excitatory and inhibitory inputs in the brain. They discuss how perturbations in three particular proteins can cause an imbalance in synaptic signals that leads to conditions such as bipolar disorder, schizophrenia and autism. The authors propose that these proteins form a “core scaffolding triad” and interact in different ways to cause different mental illnesses. Dysregulation of these proteins could explain how mutations in the same genes, depending on whether they boost or decrease gene expression, contribute to the onset of diverse psychiatric disorders.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par3">In neural circuits, the balance between excitatory and inhibitory neuronal activity (E/I balance) refers to the relative degree of excitatory and inhibitory neuronal activity<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The amount of excitatory vs. inhibitory inputs modulates the excitability and function of a single neuron, and the integration of E/I drive in a group of neurons determines the strength of neuronal activity in a certain brain circuit of a particular brain region<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Thus, the ratio between excitation and inhibition has been recognized as a crucial measure for assessing brain fitness as its imbalance is implicated in many psychiatric disorders, including autism spectrum disorder (ASD)<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, bipolar disorder (BD)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, and schizophrenia (SCZ)<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. However, measuring the E/I ratio is complicated because mixtures of disparate excitatory and inhibitory signals may represent various circuits in different brain regions. Even within a single circuit, a large flexibility between excitation and inhibition affects varying aspects of neuronal function. Despite these challenges, mutations in many of the postsynaptic proteins that affect the formation or maintenance of either excitatory or inhibitory synapses have been identified as a causative factor for the dysregulation of the E/I balance in psychiatric disorders<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Indeed, recent studies indicate that assembly of the scaffolding proteins at excitatory synapses that regulate the actin cytoskeleton in dendritic spines is critical for maintaining the synaptic E/I balance and that either up- or downregulation of these molecules is implicated in various psychiatric disorders (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Table showing the SAPAP, SHANK, and nArgBP2 subtypes expressed in the brain and the corresponding CNS diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Subtype</th><th>CNS disease</th><th>Expression level</th><th>References</th></tr></thead><tbody><tr><td rowspan="3">SAPAP1</td><td>Schizophrenia</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>
</td></tr><tr><td>Alzheimer’s disease</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>
</td></tr><tr><td>Major depressive disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>
</td></tr><tr><td rowspan="4">SAPAP2</td><td>Schizophrenia</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>
</td></tr><tr><td>Fragile X mental retardation</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>
</td></tr><tr><td>Post-traumatic stress disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>
</td></tr><tr><td>Autism spectrum disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>
</td></tr><tr><td rowspan="4">SAPAP3</td><td>Trichotillomania</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref></sup>
</td></tr><tr><td>Obsessive compulsive disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref></sup>
</td></tr><tr><td>Parkinson’s disease</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR90">90</xref></sup>
</td></tr><tr><td>Schizophrenia</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR91">91</xref></sup>
</td></tr><tr><td rowspan="2">SAPAP4</td><td>Cerebellar ataxia</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR92">92</xref></sup>
</td></tr><tr><td>Bipolar disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR93">93</xref></sup>
</td></tr><tr><td rowspan="3">SHANK1</td><td>Autism spectrum disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref></sup>
</td></tr><tr><td>Schizophrenia</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref></sup>
</td></tr><tr><td>Alzheimer’s disease</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref></sup>
</td></tr><tr><td rowspan="5">SHANK2</td><td>Autism spectrum disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR96">96</xref></sup>
</td></tr><tr><td>Schizophrenia</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR97">97</xref></sup>
</td></tr><tr><td>Bipolar disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref></sup>
</td></tr><tr><td>Intellectual disability</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR96">96</xref></sup>
</td></tr><tr><td>Alzheimer’s disease</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>
</td></tr><tr><td rowspan="8">SHANK3</td><td>Autism spectrum disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR100">100</xref>–<xref ref-type="bibr" rid="CR104">104</xref></sup>
</td></tr><tr><td>Epilepsy</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref></sup>
</td></tr><tr><td>Obsessive compulsive disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref></sup>
</td></tr><tr><td>Attention-deficit/hyperactivity disorder</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR109">109</xref></sup>
</td></tr><tr><td>Phelan–McDermid syndrome</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR110">110</xref>–<xref ref-type="bibr" rid="CR112">112</xref></sup>
</td></tr><tr><td>Schizophrenia</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR113">113</xref>–<xref ref-type="bibr" rid="CR115">115</xref></sup>
</td></tr><tr><td>Bipolar disorder</td><td>↑</td><td>
<sup><xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref></sup>
</td></tr><tr><td>Alzheimer’s disease</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref></sup>
</td></tr><tr><td rowspan="2">nArgBP2</td><td>Bipolar disorder</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR118">118</xref></sup>
</td></tr><tr><td>Intellectual disability</td><td>↓</td><td>
<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>
</td></tr></tbody></table><table-wrap-foot><p>The upward or downward arrow signifies up- or downregulation/mutation, respectively</p></table-wrap-foot></table-wrap></p>
<p id="Par4">In this review, we summarize recent studies that investigated how perturbations in the scaffolding proteins at excitatory synapses, especially focusing on nArgBP2, lead to an E/I imbalance. In addition, we propose a hypothesis that a shift in the balance of synaptic actin dynamics caused by altered interactions among nArgBP2-SAPAP-SHANK, core-postsynaptic proteins, is an important factor in the manifestation of an E/I imbalance in a specific brain region that accounts for various psychiatric disorders.</p>
</sec>
<sec id="Sec2">
<title>Dendritic spine regulation as a common mechanism of psychiatric disorders</title>
<p id="Par5">Most studies on excitatory synaptic transmission linked to E/I imbalance are focused on the proteins that regulate dendritic spines. Dendritic spines are tiny protrusions on the dendrites and serve as a structural unit, where excitatory synaptic transmission occurs<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Spines integrate excitatory signals into the output passed on to another neuron in the brain circuit<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Spines are classified according to their morphological features such as shape and size since their morphology is highly correlated with their functional properties. Spines actively participate in the formation of synapses and neuronal circuits during development<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, whereas activity-dependent spine maintenance or elimination is important for the remodeling of established neuronal circuits during postnatal and adolescent periods<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. Persistent changes in synaptic strength during synaptic plasticity also involve structural changes of spines. Indeed, spines are morphologically regulated to meet the dynamic demands of the brain and are intimately linked to higher brain function<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Molecular pathways involving the regulation of spines include cytoskeletal remodeling, trans-synaptic adhesion, receptor trafficking, protein translation, ubiquitination, and gene expression<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p>
<p id="Par6">The cytoplasm of dendritic spines is enriched with highly branched filamentous actin (F-actin) located exactly beneath the postsynaptic density (PSD). The actin cytoskeleton stabilizes and modulates the dynamic dendritic spine structure in response to neuronal activity<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, and the regulation of such dynamics is critical for the morphological changes, maturation, and physiological function of spines<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. A recent study using super-resolution imaging showed that the actin cytoskeleton is unevenly distributed and rapidly reorganized within synapses<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p>
<p id="Par7">The dendritic spine contains a large number of scaffolding proteins, including SHANK (or Pro-SAP), SAPAP (or GKAP), and nArgBP2, which share highly conserved domains for protein–protein interactions. These proteins can interact with multiple proteins simultaneously to physically connect PSD components and organize binding partners into a functional unit to enhance postsynaptic signaling<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). The specialized functional network composed of these proteins provides a direct link between membrane receptors, cell adhesion molecules, and the actin cytoskeleton, thus facilitating activity-dependent dendritic remodeling, which is critical for synaptogenesis and synaptic plasticity<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><title>The domain architectures of nArgBP2, SHANK, and SAPAP.</title><p>Proteins listed with each of the domains indicate the known binding partners. Only a subset of known interacting proteins is shown. nArgBP2, SHANK, and SAPAP interact with each other either directly via specific domains (red lines) or indirectly through common binding partners (broken lines). SAPAP interacts with nArgBP2 via its proline-rich region between the DLC and GH1 regions. 14 aa 14 amino acid domain, Abi Abelson interacting protein-1, DLC dynein light chain, GH1 GKAP homology 1, nArgBP2 neural Arg binding protein 2, PDZ PSD95 Dlg1 and zo-, 1 PSD95 postsynaptic density protein 95, SAM sterile alpha motif, SAPAP SAP90/PSD95-associated protein, SHANK SH3 and multiple ankyrin repeat domains, SH3 Src homology 3 domain, SoHo sorbin homology domain, S-SCAM synaptic scaffolding molecule, WAVE WASP (Wiskott–Aldrich syndrome protein)-family verprolin homologous protein</p></caption><graphic id="d29e949" xlink:href="12276_2017_18_Fig1_HTML"></graphic></fig></p>
<p id="Par8">Anatomical analysis often reveals altered dendritic spine morphology in the brains of patients with SCZ, intellectual disabilities, and ASDs<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Indeed, most genetic human risk factors for these disorders are associated with the signaling of actin cytoskeleton dynamics in dendritic spines<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Accordingly, various studies have reported that numerous psychiatric disorders are characterized by dendritic abnormalities, including aberrant spine density and morphology, which are most likely to significantly affect excitatory drive and subsequently E/I balance in the brain circuit<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p>
</sec>
<sec id="Sec3">
<title>Core postsynaptic proteins associated with psychiatric disorders</title>
<sec id="Sec4">
<title>SAPAP</title>
<p id="Par9">The four members of the guanylate kinase-associated protein (GKAP) family were originally identified as proteins that interact with the GK domain of PSD95<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and named SAP90/PSD95-associated protein (SAPAP) 1–4<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. SAPAPs consist of a 14-amino acid repeat domain, a dynein light chain (DLC) domain, and a GKAP homology (GH1) domain. As a scaffold protein, SAPAP binds to PSD95, synaptic scaffolding molecule (S-SCAM), nArgBP2 and dynein light chain via its N-terminal domain<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>, while it interacts with the PDZ domain of ProSAPs/SHANKs through its C-terminal domain<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).</p>
<sec id="Sec10">
<title>Implications of SAPAPs in psychiatric disorders</title>
<p id="Par11">A previous study found that SAPAP1 immunoreactivity is significantly increased in the nucleus accumbens of unmedicated patients with SCZ<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. SAPAP1 is also implicated in recurrent major depressive disorder according to a report from a study of Mexican American individuals<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Screening of genomic DNA methylation patterns in a rat post-traumatic stress disorder (PTSD) model revealed that an increase in a specific methylation site causes a reduction in <italic>SAPAP2</italic> gene expression, thus pinpointing SAPAP2 as a possible target for PTSD<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Some common and rare genetic variants of SAPAP2 have also been found to be associated with ASD<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, and increased <italic>SAPAP2</italic> gene expression contributes to the pathogenesis of SCZ<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Genetic deletion of <italic>SAPAP3</italic> in mice causes behavioral abnormalities including increased anxiety and compulsive self-grooming<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, which are similar to symptoms exhibited by human patients with obsessive compulsive disorder (OCD) and phenotypes exhibited by other genetic animal models of OCD-like behaviors<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. OCD-like behaviors in <italic>SAPAP3</italic>-null mice have been indicated in several recent human genetics studies of the role of SAPAP3 in obsessive compulsive spectrum disorder (OCSD)<sup><xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
</sec>
</sec>
<sec id="Sec5">
<title>SHANK</title>
<p id="Par12">The SH3 and multiple ankyrin repeat domains (<italic>SHANK</italic>) family is a group of scaffold proteins that contain ankyrin repeat domains, a SH3 domain, one PDZ domain, a proline-rich region (PRD), and a sterile alpha motif (SAM) domain<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. The ankyrin repeat domain, containing six ankyrin repeats, interacts with the PSD protein SHARPIN<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and binds to the cytoskeleton through an interaction with α‑spectrin (also known as α‑fodrin)<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. The PDZ domain of SHANK interacts with SAPAP1<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and the GluR1 subunit of AMPA receptors<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> and, therefore, is important for dendritic spine formation and synaptic transmission. The PRD binds to Homer<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> and cortactin<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, and such an interaction is important for cytoskeleton regulation as well as synaptic transmission and plasticity. The C‑terminal SAM domain is important for self-multimerization of the protein<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and is required for the localization of SHANK to the PSD<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). SHANK binds to SAPAP, which in turn binds to PSD95 to form a PSD95/SAPAP/SHANK postsynaptic complex<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>.</p>
<sec id="Sec11">
<title>Implications of SHANKs in psychiatric disorders</title>
<p id="Par14"><italic>SHANK</italic> genes were first identified in studies of Phelan–McDermid syndrome (PMS), a neurodevelopmental disorder that is caused by chromosome 22q13.3 deletion and characterized by autistic-like behaviors, hypotonia, and delayed or absent speech<sup><xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref></sup>. Moreover, mutations or disruptions in the <italic>SHANK</italic> gene family account for ~1% of all patients with ASD<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
<p id="Par15"><italic>SHANK1</italic> (also known as <italic>ProSAP3</italic>) deletions and mutations have been reported to cause broad autism phenotypes in males<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. A recent study also found a de novo <italic>SHANK1</italic> mutation in a female with ASD<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Lennerts et al. found that the T allele of SNP rs3810280 in the <italic>SHANK1</italic> promoter is associated with reduced auditory working memory in patients with SCZ<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, and Fromer et al. reported a de novo <italic>SHANK1</italic> frameshift mutation in a female schizophrenia patient<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>.</p>
<p id="Par16">Several studies have identified deleterious mutations of <italic>SHANK2</italic> (also known as <italic>ProSAP1</italic>) in patients with ASD and mild/moderate intellectual disability (ID)<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR56">56</xref></sup>. Missense variants of <italic>SHANK2</italic> identified in SCZ patients correspond to a mutation in hippocampal neurons that leads to a loss of presynaptic contacts and reduced clustering of SHANK2 at synapses<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p>
<p id="Par17"><italic>SHANK3</italic> (also known as<italic> ProSAP2</italic>) is the best studied among the three <italic>SHANK</italic> family members, and its mutant mice exhibit autistic-like behaviors, including impaired social interaction and repetitive behaviors. SHANK3 was first recognized in PMS<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and later in ASD<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> with symptoms that include ID, autistic behaviors, hypotonia, and significant language impairment<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. In addition, duplication of the <italic>SHANK3</italic> gene is often found in patients diagnosed with BD, and mice with an extra copy of <italic>SHANK3</italic> exhibit manic-like phenotypes<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. A recent study further found that mice with the ASD-linked InsG3680 mutation in SHANK3 show defective synaptic transmission in the striatum and impaired juvenile social interaction, coinciding with the early onset of ASD symptoms, while adult mice carrying the schizophrenia-linked R1117X mutation show profound synaptic defects in the prefrontal cortex and social dominance behavior<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>.</p>
</sec>
</sec>
<sec id="Sec6">
<title>nArgBP2</title>
<sec id="Sec7">
<title>Domain structure of nArgBP2</title>
<p id="Par18">nArgBP2 is a neural variant of ArgBP2 (Arg binding protein 2, also known as SORBS2) and was first cloned from the rat brain as an SAPAP-binding protein<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The full-length protein is composed of 1196 amino acids containing multiple domains for protein–protein interaction including a sorbin homology (SoHo) domain in the N-terminal region and three Src homology 3 (SH3) domains in the C-terminal region<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. nArgBP2 has one zinc-finger motif in the middle region (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).</p>
</sec>
<sec id="Sec12">
<title>Expression patterns of nArgBP2 mRNAs and proteins</title>
<p id="Par20">The <italic>SORBS2</italic> gene encodes multiple transcripts including four ArgBP2 isoforms (α, β, γ, and δ isoform) and nArgBP2 through alternative RNA splicing<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref></sup>. ArgBP2/nArgBP2 isoforms are widely expressed in human tissues and are especially abundant in the brain, heart, pancreas, and colon<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. A transcript corresponding to an nArgBP2-specific exon is detected only in the brain tissue and exclusively in neurons<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. In the brain, nArgBP2 mRNA is highly expressed in the isocortex, hippocampus, cortical subplate, striatum, thalamus, and hypothalamus, the majority of which are regions of the brain associated with BD<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR67">67</xref></sup>. At the protein level, nArgBP2 is only detected in the brain with a high expression level in the cortex, amygdala, and dentate gyrus (DG) and moderate expression level in the striatum, lateral habenula, and thalamus. Within cortical regions, immunoreactivity for nArgBP2 is more intense in layers I–III in the neocortex and layer I of the piriform cortex. In the DG, nArgBP2 is specifically enriched at the edge of the molecular layer<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>.</p>
</sec>
<sec id="Sec13">
<title>Protein interactions of nArgBP2</title>
<p id="Par22">nArgBP2 is a scaffold protein that controls the balance between adhesion and motility by modulating the function of multiple signaling pathways that converge on the actin cytoskeleton<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. The N-terminal SoHo domain interacts with α2-spectrin, and the three SH3 domains have partially overlapping binding partners, with the second SH3 having the most interactors including SAPAP<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, synaptojanin1/2<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>, vinculin<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, Abl<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, Cbl<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>, and dynamin1/2<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. Other interactors include the actin-regulating Wiskott–Aldrich syndrome protein family verprolin homologous protein (WAVE) 1 and 2 and components of a WAVE regulatory complex (PIR121 and Nap1)<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>.</p>
<p id="Par23">ArgBP2 mediates the formation of a complex containing Abl and Cbl, which promotes the Abl-dependent phosphorylation of Cbl and the ubiquitination by Cbl of both Abl and ArgBP2<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. In the brain, Abl interacts with Abelson interacting protein-1 (Abi-1), which binds to SHANK and is essential for dendrite morphogenesis and synapse formation<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. nArgBP2 interacts with SHANK either directly or indirectly through SAPAP<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, suggesting a possible network formation among nArgBP2, SAPAP, and SHANK.</p>
</sec>
<sec id="Sec14">
<title>Synaptic localization of nArgBP2</title>
<p id="Par25">In rat brain subcellular fractions, nArgBP2 is detected in the cytosol of the synaptosome but is also enriched in the PSD fraction<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Immunocytochemistry analysis with specific nArgBP2 antibodies indicates that nArgBP2 colocalizes with F-actin and is enriched in both dendritic and axonal terminals in early developing neurons<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. In mature neurons, nArgBP2 is mainly enriched in dendrites, especially in dendritic spines in which it colocalizes with the excitatory postsynaptic scaffolding protein PSD95<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR73">73</xref></sup>. Dendritic clusters of nArgBP2 are also juxtaposed with vesicular glutamate transporter 1 (vGLUT1) puncta in spiny neurons<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. In contrast, nArgBP2 rarely overlaps with the inhibitory postsynaptic scaffolding protein gephyrin in spiny neurons and is almost absent in aspiny gephyrin-positive neurons<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Collectively, these observations show that nArgBP2 primarily localizes to excitatory synapses in spiny pyramidal neurons and plays a specific functional role in these excitatory synapses.</p>
</sec>
<sec id="Sec15">
<title>nArgBP2 in dendritic spine formation</title>
<p id="Par27">Recently, Zhang<italic> et al.</italic> found that dendritic arborization of DG granule cells in <italic>nArgBP2</italic>KO mice shows much less complexity with a significantly reduced number of dendritic branch points than those in wild-type (WT) littermates<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. We also found that the density of total dendritic protrusions and the proportion of mushroom-shaped spines are dramatically decreased with <italic>nArgBP2</italic> knockdown (KD)<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Additionally, the expression level of the active form of WAVE1 is increased in <italic>nArgBP2</italic> KD<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>, and Rac1 activity is enhanced, leading to p21-activated kinase (PAK) activation and cofilin inactivation. Dendritic spines in KD neurons are highly motile, and the pool of dynamic actin downstream of Rac1 activation is significantly increased accordingly<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p>
</sec>
<sec id="Sec16">
<title>nArgBP2 in the regulation of excitatory synaptic formation and transmission</title>
<p id="Par29"><italic>nArgBP2</italic> KD causes a specific and dramatic reduction in the number of spine-synapses, which is consistent with the decreased number of mushroom-shaped spines in KD neurons<sup><xref ref-type="bibr" rid="CR73">73</xref></sup> (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Furthermore, the mean frequency of miniature excitatory postsynaptic currents (mEPSCs) is significantly decreased compared to that in control neurons, while that of miniature inhibitory postsynaptic currents (mIPSCs) is not affected<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Consistently, in <italic>nArgBP2</italic> KO mice, the mean frequency of mEPSCs is also significantly reduced compared with that in WT littermates<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. These findings indicate that nArgBP2 functions to regulate spine morphogenesis and subsequent spine-synapse formation at glutamatergic synapses and that its ablation causes a robust and selective inhibition of excitatory synapse formation by controlling actin cytoskeleton dynamics (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Schematic description of the role of nArgBP2 in excitatory spine-synapse formation and maintenance of E/I balance.</title><p>In the normal condition, nArgBP2 plays a role in controlling actin cytoskeleton dynamics through the WAVE and PAK/cofilin cascade. Its ablation, however, increases actin dynamics via uncontrolled phosphorylation of the WAVE/PAK/cofilin pathway, causing a robust and selective inhibition of excitatory spine-synapse formation. This subsequently leads to an excitatory/inhibitory synaptic imbalance. Since the excitatory/inhibitory synaptic imbalance likely leads to a broad spectrum of psychiatric disorders, <italic>nArgBP2</italic> KD, which selectively alters excitatory synapse formation, may account for the manic/bipolar-like behaviors observed in <italic>nArgBP2</italic> KO mice</p></caption><graphic id="d29e1448" xlink:href="12276_2017_18_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec17">
<title>Behavioral phenotypes of <italic>nArgBP2</italic> KO mice and implications of <italic>nArgBP2</italic> in psychiatric disorders</title>
<p id="Par31"><italic>nArgBP2</italic> KO mice have been reported to display manic/bipolar-like behavior including increased activity, compulsive/repetitive behavior, risk-taking behavior, hedonistic behavior, and anti-depressant-like behavior, resembling many aspects of symptoms in BD patients<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Additional behavioral phenotypes include altered long-term but not short-term object recognition memory, as well as impaired contextual fear memory<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. A specific defect in contextual fear memory but not toned fear memory implies that nArgBP2 may have a more important role in the hippocampus than in the amygdala<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. <italic>nArgBP2</italic> KO mice also show a reduced dendritic complexity of DG granule cells<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>, which has also been shown in other mouse models of ID<sup><xref ref-type="bibr" rid="CR76">76</xref>,<xref ref-type="bibr" rid="CR77">77</xref></sup>, supporting the link between the mutation of <italic>nArgBP2</italic> and ID<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. nArgBP2 de novo mutations are also found in SCZ patients<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>.</p>
</sec>
</sec>
</sec>
<sec id="Sec8">
<title>Postsynaptic triad of nArgBP2-SAPAP-SHANK, a convergent pathway of psychiatric disorders</title>
<p id="Par32">Data from a large-scale study revealed that there are a substantial number of individuals who simultaneously meet the criteria for two or more psychiatric disorders. For example, comorbid BD and OCD are relatively common among patients with a primary diagnosis of BD<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. Studies have also found that as many as 27% of those with ASD also have symptoms of BD<sup><xref ref-type="bibr" rid="CR79">79</xref>,<xref ref-type="bibr" rid="CR80">80</xref></sup>. Similarly, there is a strong positive correlation between measures of the severity of both depression and anxiety symptoms<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. Indeed, recent genome-wide genetic studies have further identified overlapping risk genes across the major psychiatric disorders, including SCZ, BD, major depressive disorder, and ASD<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR84">84</xref></sup>. These results indicate that dysregulation of the same gene can cause different types of disorders, further suggesting the existence of a convergent mechanism for various psychiatric disorders with multiple etiologies.</p>
<p id="Par33">Recent studies suggest that deletion or overexpression of postsynaptic proteins, such as nArgBP2, SAPAP, and SHANK, leads to behavioral phenotypes that are similar to symptoms observed in human ASD, BD, SCZ, and OCD<sup><xref ref-type="bibr" rid="CR59">59</xref>,<xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR74">74</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup>. Deletion of SAPAP causes OCD-like behaviors<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, some genetic variants of SAPAP2 are associated with ASD<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, and increased SAPAP2 expression contributes to the pathogenesis of SCZ<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. In addition, SHANK3 deletion or mutation is associated with ASD<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>, and its duplication or other mutations result in BD-like manic behaviors<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> or SCZ-like behaviors<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>. Deletion of nArgBP2 causes ID and BD-like symptoms<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>. Interestingly, SHANK binds to the GH1 domain of SAPAP directly via its PDZ domain. SAPAP binds to the SH3 domain of nArgBP2 via its proline-rich region. nArgBP2 and SHANK share a number of proteins as common binding partners (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Therefore, these three major postsynaptic proteins indeed interact with each other in dendritic spines of excitatory synapses such that the high incidence of comorbidity among psychiatric disorders is comprehensible. Although the underlying molecular mechanisms that connect the aberrant expression of these genes and behavioral consequences are still far from elucidated, E/I imbalance caused by dysregulation of the actin cytoskeleton in dendritic spines has been suggested as a shared key molecular mechanism.</p>
<p id="Par34">Here, we propose a hypothesis that nArgBP2, SAPAP, and SHANK form a core scaffolding triad and together regulate actin cytoskeleton in dendritic spines. Different levels of expression or activity of this core triad may result in different phenotypes of psychiatric disorders in a brain region-specific manner, thus asserting that actin regulation by the core triad in dendritic spines is a convergent mechanism for psychiatric disorders (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). Similar to each point of an equilateral triangle, these three proteins interact with each other to form a structural and functional postsynaptic scaffold that organizes multiple protein interactions to regulate the actin cytoskeleton in dendritic spines. Altered expression or mutation of either one or more of the proteins in the core triad in a specific brain region would break the balance of the interactome and induce defects in actin regulation, leading to spine structure abnormalities and, subsequently, to defects in the excitatory synaptic integrity. Depending on which individual protein is affected and, accordingly, which distinct protein network is disrupted, the E/I balance may be differently altered at molecular, synaptic, and circuit levels in a brain region-specific manner, and these differences will be the contributing factors for the diverse phenotypes of psychiatric disorders. Through the combination of genetic approaches and recently developed imaging techniques, the identification of critical brain regions and neuronal types in which the core triad protein complex of nArgBP2, SAPAP, and SHANK differentially regulates synaptic function will help us to test and advance this tempting hypothesis.<fig id="Fig3"><label>Fig. 3</label><caption><title>Hypothetical model proposing the postsynaptic triad of nArgBP2-SAPAP-SHANK as a convergent pathway of psychiatric disorders.</title><p>nArgBP2, SAPAP, and SHANK interact with each other, forming a structural and functional postsynaptic scaffold. They also organize multiple interactomes to regulate the actin cytoskeleton. Alterations in the expression of either one or more of the proteins participating in the core triad would break the interactome balance and induce actin cytoskeleton dysregulation, leading to abnormal spine formation and morphogenesis, which consequently undermines excitatory synapse formation. Depending on levels of expression or activity of this core triad in a specific brain region, diverse levels of E/I imbalance may lead to the numerous phenotypes of psychiatric disorders. Thus, actin regulation by the core triad in dendritic spines is a convergent mechanism for various psychiatric disorders such as ASD, BD, OCD, and SCZ</p></caption><graphic id="d29e1595" xlink:href="12276_2017_18_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec9" sec-type="conclusion">
<title>Conclusion</title>
<p id="Par35">Considering the high diversity and complexity of psychiatric disorders, it is surprising that many risk genes are shared by multiple psychiatric disorders and that many of these risk genes are regulators of actin cytoskeleton signaling in dendritic spines. Consistently, accumulating evidence suggests that alterations in dendritic spine morphology are a shared molecular etiology across different psychiatric disorders. We propose that nArgBP2, SAPAP, and SHANK form the core scaffolding triad to precisely mediate actin regulation in dendritic spines and that this serves as a convergent mechanism for different psychiatric disorders. Further studies on the brain region-specific regulation of actin dynamics by the core triad will be necessary to better understand the molecular mechanisms of various psychiatric disorders.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>This research was supported by grants from the Brain Research Program (NRF-2015M3C7A1028790 and 2017M3C7A1044957-8) to S.C. through the National Research Foundation of Korea funded by the Ministry of Science, ICT &amp; Future Planning, Republic of Korea. This work was also supported by the Education and Research Encouragement Fund of Seoul National University Hospital.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors' contributions</title>
<p>S.-E.L. and S.C. contributed to the literature search. S.-E.L., J.A.K., and S.C. discussed all content of the manuscript and wrote the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Conflict of interest</title>
<p id="Par36">The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Buonanno</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Passafaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sweet</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders</article-title>
<source/>J. Neurochem.
          <year>2013</year>
<volume>126</volume>
<fpage>165</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">23574039</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A synaptic trek to autism</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2009</year>
<volume>19</volume>
<fpage>231</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="pmid">19545994</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Postnatal neurodevelopmental disorders: meeting at the synapse?</article-title>
<source/>Science
          <year>2003</year>
<volume>302</volume>
<fpage>826</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="pmid">14593168</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Merzenich</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>
<source/>Genes Brain Behav.
          <year>2003</year>
<volume>2</volume>
<fpage>255</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="pmid">14606691</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benes</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Berretta</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder</article-title>
<source/>Neuropsychopharmacology
          <year>2001</year>
<volume>25</volume>
<fpage>1</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">11377916</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoftman</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Datta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Layer 3 excitatory and inhibitory circuitry in the prefrontal cortex: developmental trajectories and alterations in schizophrenia</article-title>
<source/>Biol. Psychiatry
          <year>2017</year>
<volume>81</volume>
<fpage>862</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="pmid">27455897</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Excitation/inhibition imbalance in animal models of autism spectrum disorders</article-title>
<source/>Biol. Psychiatry
          <year>2017</year>
<volume>81</volume>
<fpage>838</fpage>
<lpage>847</lpage>
<pub-id pub-id-type="pmid">27450033</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourne</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Balancing structure and function at hippocampal dendritic spines</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2008</year>
<volume>31</volume>
<fpage>47</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">18284372</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spruston</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Pyramidal neurons: dendritic structure and synaptic integration</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2008</year>
<volume>9</volume>
<fpage>206</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">18270515</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holtmaat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Svoboda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Experience-dependent structural synaptic plasticity in the mammalian brain</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2009</year>
<volume>10</volume>
<fpage>647</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="pmid">19693029</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Anatomical and physiological plasticity of dendritic spines</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2007</year>
<volume>30</volume>
<fpage>79</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">17280523</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>WB</given-names>
</name>
</person-group>
<article-title>Development of long-term dendritic spine stability in diverse regions of cerebral cortex</article-title>
<source/>Neuron
          <year>2005</year>
<volume>46</volume>
<fpage>181</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">15848798</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Dendritic spine dynamics--a key role for kalirin-7</article-title>
<source/>Trends Neurosci.
          <year>2008</year>
<volume>31</volume>
<fpage>419</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">18597863</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of dendritic spine morphogenesis</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2006</year>
<volume>16</volume>
<fpage>95</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">16361095</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bosch</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural and molecular remodeling of dendritic spine substructures during long-term potentiation</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>444</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="pmid">24742465</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frost</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Blanpied</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>A network of networks: cytoskeletal control of compartmentalized function within dendritic spines</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2010</year>
<volume>20</volume>
<fpage>578</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="pmid">20667710</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korobova</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Svitkina</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis</article-title>
<source/>Mol. Biol. Cell
          <year>2010</year>
<volume>21</volume>
<fpage>165</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">19889835</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urban</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Willig</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Hell</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Nagerl</surname>
<given-names>UV</given-names>
</name>
</person-group>
<article-title>STED nanoscopy of actin dynamics in synapses deep inside living brain slices</article-title>
<source/>Biophys. J.
          <year>2011</year>
<volume>101</volume>
<fpage>1277</fpage>
<lpage>1284</lpage>
<pub-id pub-id-type="pmid">21889466</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Peca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2012</year>
<volume>35</volume>
<fpage>49</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">22540979</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <year>2012</year>
<volume>4</volume>
<fpage>a009886</fpage>
<pub-id pub-id-type="pmid">22258914</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Dendritic spines: the locus of structural and functional plasticity</article-title>
<source/>Physiol. Rev.
          <year>2014</year>
<volume>94</volume>
<fpage>141</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">24382885</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>VanLeeuwen</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Woolfrey</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>
<source/>Nat. Neurosci.
          <year>2011</year>
<volume>14</volume>
<fpage>285</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">21346746</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules</article-title>
<source/>J. Cell Biol.
          <year>1997</year>
<volume>136</volume>
<fpage>669</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="pmid">9024696</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density</article-title>
<source/>J. Biol. Chem.
          <year>1997</year>
<volume>272</volume>
<fpage>11943</fpage>
<lpage>11951</lpage>
<pub-id pub-id-type="pmid">9115257</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naisbitt</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<fpage>4524</fpage>
<lpage>4534</lpage>
<pub-id pub-id-type="pmid">10844022</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawabe</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>nArgBP2, a novel neural member of ponsin/ArgBP2/vinexin family that interacts with synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP)</article-title>
<source/>J. Biol. Chem.
          <year>1999</year>
<volume>274</volume>
<fpage>30914</fpage>
<lpage>30918</lpage>
<pub-id pub-id-type="pmid">10521485</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verpelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schmeisser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>Scaffold proteins at the postsynaptic density</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2012</year>
<volume>970</volume>
<fpage>29</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">22351050</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kajimoto</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia</article-title>
<source/>Neuropsychopharmacology
          <year>2003</year>
<volume>28</volume>
<fpage>1831</fpage>
<lpage>1839</lpage>
<pub-id pub-id-type="pmid">12784099</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathias</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent major depression and right hippocampal volume: a bivariate linkage and association study</article-title>
<source/>Hum. Brain Mapp.
          <year>2016</year>
<volume>37</volume>
<fpage>191</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="pmid">26485182</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chertkow-Deutsher</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ben-Shachar</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>DNA methylation in vulnerability to post-traumatic stress in rats: evidence for the role of the post-synaptic density protein Dlgap2</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2010</year>
<volume>13</volume>
<fpage>347</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="pmid">19793403</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">20531469</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of the DLGAP2 gene encoding the SAP90/PSD-95-associated protein 2 in schizophrenia</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<fpage>e85373</fpage>
<pub-id pub-id-type="pmid">24416398</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welch</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice</article-title>
<source/>Nature
          <year>2007</year>
<volume>448</volume>
<fpage>894</fpage>
<lpage>900</lpage>
<pub-id pub-id-type="pmid">17713528</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shmelkov</surname>
<given-names>SV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice</article-title>
<source/>Nat. Med.
          <year>2010</year>
<volume>16</volume>
<fpage>598</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="pmid">20418887</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bienvenu</surname>
<given-names>OJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2009</year>
<volume>150B</volume>
<fpage>710</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="pmid">19051237</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boardman</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Investigating SAPAP3 variants in the etiology of obsessive-compulsive disorder and trichotillomania in the South African white population</article-title>
<source/>Compr. Psychiatry
          <year>2011</year>
<volume>52</volume>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">21295225</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuchner</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple rare SAPAP3 missense variants in trichotillomania and OCD</article-title>
<source/>Mol. Psychiatry
          <year>2009</year>
<volume>14</volume>
<fpage>6</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">19096451</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development</article-title>
<source/>J. Biol. Chem.
          <year>1999</year>
<volume>274</volume>
<fpage>29510</fpage>
<lpage>29518</lpage>
<pub-id pub-id-type="pmid">10506216</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2001</year>
<volume>17</volume>
<fpage>385</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">11178875</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bockers</surname>
<given-names>TM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin</article-title>
<source/>J. Biol. Chem.
          <year>2001</year>
<volume>276</volume>
<fpage>40104</fpage>
<lpage>40112</lpage>
<pub-id pub-id-type="pmid">11509555</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naisbitt</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</article-title>
<source/>Neuron
          <year>1999</year>
<volume>23</volume>
<fpage>569</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="pmid">10433268</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchino</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synaptic molecule Shank3 with GluR1 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</article-title>
<source/>J. Neurochem.
          <year>2006</year>
<volume>97</volume>
<fpage>1203</fpage>
<lpage>1214</lpage>
<pub-id pub-id-type="pmid">16606358</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</article-title>
<source/>Neuron
          <year>1999</year>
<volume>23</volume>
<fpage>583</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="pmid">10433269</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3</article-title>
<source/>J. Neurochem.
          <year>2005</year>
<volume>92</volume>
<fpage>519</fpage>
<lpage>524</lpage>
<pub-id pub-id-type="pmid">15659222</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>PDZ domain proteins of synapses</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2004</year>
<volume>5</volume>
<fpage>771</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="pmid">15378037</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaglia</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the ProSAP2 gene in a t(12;22)(q24.1; q13.3) is associated with the 22q13.3 deletion syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2001</year>
<volume>69</volume>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="pmid">11431708</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phelan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McDermid</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>The 22q13.3 deletion syndrome (Phelan-McDermid Syndrome)</article-title>
<source/>Mol. Syndromol.
          <year>2012</year>
<volume>2</volume>
<fpage>186</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="pmid">22670140</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watt</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A familial pericentric inversion of chromosome 22 with a recombinant subject illustrating a ‘pure’ partial monosomy syndrome</article-title>
<source/>J. Med. Genet.
          <year>1985</year>
<volume>22</volume>
<fpage>283</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="pmid">4045954</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments</article-title>
<source/>PLoS Genet.
          <year>2014</year>
<volume>10</volume>
<fpage>e1004580</fpage>
<pub-id pub-id-type="pmid">25188300</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SHANK1 deletions in males with autism spectrum disorder</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>90</volume>
<fpage>879</fpage>
<lpage>887</lpage>
<pub-id pub-id-type="pmid">22503632</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo genic mutations among a Chinese autism spectrum disorder cohort</article-title>
<source/>Nat. Commun.
          <year>2016</year>
<volume>7</volume>
<fpage>13316</fpage>
<pub-id pub-id-type="pmid">27824329</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennertz</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2012</year>
<volume>262</volume>
<fpage>117</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">21901269</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">24463507</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chilian</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci</article-title>
<source/>Clin. Genet.
          <year>2013</year>
<volume>84</volume>
<fpage>560</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="pmid">23350639</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders</article-title>
<source/>PLoS Genet.
          <year>2012</year>
<volume>8</volume>
<fpage>e1002521</fpage>
<pub-id pub-id-type="pmid">22346768</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schluth-Bolard</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations</article-title>
<source/>J. Med. Genet.
          <year>2013</year>
<volume>50</volume>
<fpage>144</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="pmid">23315544</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peykov</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification and functional characterization of rare SHANK2 variants in schizophrenia</article-title>
<source/>Mol. Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>1489</fpage>
<lpage>1498</lpage>
<pub-id pub-id-type="pmid">25560758</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>7863</fpage>
<lpage>7868</lpage>
<pub-id pub-id-type="pmid">20385823</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties</article-title>
<source/>Nature
          <year>2013</year>
<volume>503</volume>
<fpage>72</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">24153177</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>147</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="pmid">26687841</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cestra</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Toomre</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The Abl/Arg substrate ArgBP2/nArgBP2 coordinates the function of multiple regulatory mechanisms converging on the actin cytoskeleton</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2005</year>
<volume>102</volume>
<fpage>1731</fpage>
<lpage>1736</lpage>
<pub-id pub-id-type="pmid">15659545</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murase</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell biological characterization of a multidomain adaptor protein, ArgBP2, in epithelial NMuMG cells, and identification of a novel short isoform</article-title>
<source/>Med. Mol. Morphol.
          <year>2012</year>
<volume>45</volume>
<fpage>22</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">22431180</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<mixed-citation publication-type="other">Wang, B., Golemis, E. A. &amp; Kruh, G. D. ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. <italic>J. Biol. Chem.</italic><bold>272</bold>, 17542–17550 (1997).</mixed-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>ZQ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival</article-title>
<source/>J. Biol. Chem.
          <year>2005</year>
<volume>280</volume>
<fpage>21483</fpage>
<lpage>21490</lpage>
<pub-id pub-id-type="pmid">15784622</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired dendritic development and memory in Sorbs2 knock-out mice</article-title>
<source/>J. Neurosci.
          <year>2016</year>
<volume>36</volume>
<fpage>2247</fpage>
<lpage>2260</lpage>
<pub-id pub-id-type="pmid">26888934</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lein</surname>
<given-names>ES</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide atlas of gene expression in the adult mouse brain</article-title>
<source/>Nature
          <year>2007</year>
<volume>445</volume>
<fpage>168</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">17151600</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Delbello</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings</article-title>
<source/>Mol. Psychiatry
          <year>2005</year>
<volume>10</volume>
<fpage>105</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">15340357</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zucconi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dente</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Santonico</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castagnoli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cesareni</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of synaptojanin 1</article-title>
<source/>J. Mol. Biol.
          <year>2001</year>
<volume>307</volume>
<fpage>1329</fpage>
<lpage>1339</lpage>
<pub-id pub-id-type="pmid">11292345</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soubeyran</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barac</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szymkiewicz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dikic</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl</article-title>
<source/>Biochem. J.
          <year>2003</year>
<volume>370</volume>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">12475393</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rohatgi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Podtelejnikov</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kirschner</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck</article-title>
<source/>Nature
          <year>2002</year>
<volume>418</volume>
<fpage>790</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="pmid">12181570</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Innocenti</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abi1 is essential for the formation and activation of a WAVE2 signalling complex</article-title>
<source/>Nat. Cell Biol.
          <year>2004</year>
<volume>6</volume>
<fpage>319</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="pmid">15048123</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proepper</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation</article-title>
<source/>EMBO J.
          <year>2007</year>
<volume>26</volume>
<fpage>1397</fpage>
<lpage>1409</lpage>
<pub-id pub-id-type="pmid">17304222</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>nArgBP2 regulates excitatory synapse formation by controlling dendritic spine morphology</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>6749</fpage>
<lpage>6754</lpage>
<pub-id pub-id-type="pmid">27226294</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<mixed-citation publication-type="other">Feng G. US patent 20,100,077,493 (2010). Genes and pathways involved in bipolar disorder.</mixed-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maren</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Liberzon</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>The contextual brain: implications for fear conditioning, extinction and psychopathology</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2013</year>
<volume>14</volume>
<fpage>417</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="pmid">23635870</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rescue of the genetically engineered Cul4b mutant mouse as a potential model for human X-linked mental retardation</article-title>
<source/>Hum. Mol. Genet.
          <year>2012</year>
<volume>21</volume>
<fpage>4270</fpage>
<lpage>4285</lpage>
<pub-id pub-id-type="pmid">22763239</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation</article-title>
<source/>J. Physiol.
          <year>2012</year>
<volume>590</volume>
<fpage>763</fpage>
<lpage>776</lpage>
<pub-id pub-id-type="pmid">22124149</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Obsessive compulsive symptoms in bipolar disorder patients: a comorbid disorder or a subtype of bipolar disorder?</article-title>
<source/>Shanghai Arch. Psychiatry
          <year>2015</year>
<volume>27</volume>
<fpage>249</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">26549962</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borue</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Longitudinal course of bipolar disorder in youth with high-functioning autism spectrum disorder</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>2016</year>
<volume>55</volume>
<fpage>1064</fpage>
<lpage>1072.e6</lpage>
<pub-id pub-id-type="pmid">27871641</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanzada</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Manzardo</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Gene analytics pathway analysis and genetic overlap among autism spectrum disorder, bipolar disorder and schizophrenia</article-title>
<source/>Int J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<fpage>527</fpage>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemeroff</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>Comorbidity of mood and anxiety disorders: the rule, not the exception?</article-title>
<source/>Am. J. Psychiatry
          <year>2002</year>
<volume>159</volume>
<fpage>3</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">11772680</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Cross-Disorder Group of the Psychiatric Genomics C</collab>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>984</fpage>
<lpage>994</lpage>
<pub-id pub-id-type="pmid">23933821</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodbury-Smith</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Combined genome-wide linkage and targeted association analysis of head circumference in autism spectrum disorder families</article-title>
<source/>J. Neurodev. Disord.
          <year>2017</year>
<volume>9</volume>
<fpage>5</fpage>
<pub-id pub-id-type="pmid">28289475</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nyholt</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders</article-title>
<source/>Hum. Genet.
          <year>2017</year>
<volume>136</volume>
<fpage>263</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="pmid">28035465</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2011</year>
<volume>156B</volume>
<fpage>949</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="pmid">21990008</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durand</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>
<source/>Nat. Genet.
          <year>2007</year>
<volume>39</volume>
<fpage>25</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">17173049</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Sena Cortabitarte</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Investigation of SHANK3 in schizophrenia</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2017</year>
<volume>174</volume>
<fpage>390</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="pmid">28371232</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Livrea</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>OF</given-names>
</name>
</person-group>
<article-title>CDK5 is essential for soluble amyloid beta-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e23097</fpage>
<pub-id pub-id-type="pmid">21829588</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schutt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Falley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kreienkamp</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kindler</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>25479</fpage>
<lpage>25487</lpage>
<pub-id pub-id-type="pmid">19640847</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Gene expression profiling predicts pathways and genes associated with Parkinson’s disease</article-title>
<source/>Neurol. Sci.
          <year>2016</year>
<volume>37</volume>
<fpage>73</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">26269422</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exonic resequencing of the DLGAP3 gene as a candidate gene for schizophrenia</article-title>
<source/>Psychiatry Res.
          <year>2013</year>
<volume>208</volume>
<fpage>84</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">23414653</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minocherhomji</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic remodelling and dysregulation of DLGAP4 is linked with early-onset cerebellar ataxia</article-title>
<source/>Hum. Mol. Genet.
          <year>2014</year>
<volume>23</volume>
<fpage>6163</fpage>
<lpage>6176</lpage>
<pub-id pub-id-type="pmid">24986922</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bipolar disorder associated microRNA, miR-1908-5p, regulates the expression of genes functioning in neuronal glutamatergic synapses</article-title>
<source/>Exp. Neurobiol.
          <year>2016</year>
<volume>25</volume>
<fpage>296</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">28035180</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hutzler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wegerich</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Livrea</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>OF</given-names>
</name>
</person-group>
<article-title>Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways</article-title>
<source/>PLoS ONE
          <year>2009</year>
<volume>4</volume>
<fpage>e6011</fpage>
<pub-id pub-id-type="pmid">19547699</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pham</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progressive accumulation of amyloid-beta oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins</article-title>
<source/>FEBS J.
          <year>2010</year>
<volume>277</volume>
<fpage>3051</fpage>
<lpage>3067</lpage>
<pub-id pub-id-type="pmid">20573181</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkel</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>489</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="pmid">20473310</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers</article-title>
<source/>JCI Insight
          <year>2017</year>
<volume>2</volume>
<fpage>e92052</fpage>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2014</year>
<volume>165B</volume>
<fpage>303</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">24700553</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lippa</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Rosso</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer’s disease</article-title>
<source/>Brain Res.
          <year>2009</year>
<volume>1292</volume>
<fpage>191</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">19635471</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monteiro</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>SHANK proteins: roles at the synapse and in autism spectrum disorder</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2017</year>
<volume>18</volume>
<fpage>147</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">28179641</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peca</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>
<source/>Nature
          <year>2011</year>
<volume>472</volume>
<fpage>437</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">21423165</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connolly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>A genome-wide investigation into parent-of-origin effects in autism spectrum disorder identifies previously associated genes including SHANK3</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2017</year>
<volume>25</volume>
<fpage>234</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="pmid">27876814</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel de novo SHANK3 mutation in autistic patients</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2009</year>
<volume>150b</volume>
<fpage>421</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="pmid">18615476</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moessner</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of SHANK3 mutations to autism spectrum disorder</article-title>
<source/>Am. J. Hum. Genet.
          <year>2007</year>
<volume>81</volume>
<fpage>1289</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="pmid">17999366</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of SHANK3 in the temporal neocortex of patients with intractable temporal epilepsy and epilepsy rat models</article-title>
<source/>Cell. Mol. Neurobiol.
          <year>2017</year>
<volume>37</volume>
<fpage>857</fpage>
<lpage>867</lpage>
<pub-id pub-id-type="pmid">27592227</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holder</surname>
<given-names>JL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Quach</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations</article-title>
<source/>Epilepsia
          <year>2016</year>
<volume>57</volume>
<fpage>1651</fpage>
<lpage>1659</lpage>
<pub-id pub-id-type="pmid">27554343</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaramillo</surname>
<given-names>TC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered striatal synaptic function and abnormal behaviour in Shank3 exon4-9 deletion mouse model of autism</article-title>
<source/>Autism Res.
          <year>2016</year>
<volume>9</volume>
<fpage>350</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="pmid">26559786</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative analysis of brain region-specific Shank3 interactomes for understanding the heterogeneity of neuronal pathophysiology related to SHANK3 mutations</article-title>
<source/>Front. Mol. Neurosci.
          <year>2017</year>
<volume>10</volume>
<fpage>110</fpage>
<pub-id pub-id-type="pmid">28469556</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Failla</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia in a patient with subtelomeric duplication of chromosome 22q</article-title>
<source/>Clin. Genet.
          <year>2007</year>
<volume>71</volume>
<fpage>599</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="pmid">17539913</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3</article-title>
<source/>Hum. Mol. Genet.
          <year>2011</year>
<volume>20</volume>
<fpage>3093</fpage>
<lpage>3108</lpage>
<pub-id pub-id-type="pmid">21558424</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verhoeven</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Egger</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>de Leijer</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?</article-title>
<source/>Neuropsychiatr. Dis. Treat.
          <year>2012</year>
<volume>8</volume>
<fpage>175</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">22570549</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phelan</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Deletion 22q13.3 syndrome</article-title>
<source/>Orphanet J. Rare Dis.
          <year>2008</year>
<volume>3</volume>
<fpage>14</fpage>
<pub-id pub-id-type="pmid">18505557</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girard</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation burden of rare variants in schizophrenia candidate genes</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0128988</fpage>
<pub-id pub-id-type="pmid">26039597</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabrucker</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation</article-title>
<source/>Exp. Neurol.
          <year>2014</year>
<volume>253</volume>
<fpage>126</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="pmid">24382453</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundararajan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Manzardo</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases</article-title>
<source/>Gene
          <year>2018</year>
<volume>641</volume>
<fpage>25</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">29032150</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denayer</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: presence of bipolar disorder and progressive loss of skills</article-title>
<source/>Mol. Syndromol.
          <year>2012</year>
<volume>3</volume>
<fpage>14</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">22855650</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vucurovic</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion</article-title>
<source/>Eur. J. Med. Genet.
          <year>2012</year>
<volume>55</volume>
<fpage>625</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="pmid">22922660</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A susceptibility locus for bipolar affective disorder on chromosome 4q35</article-title>
<source/>Am. J. Hum. Genet.
          <year>1998</year>
<volume>62</volume>
<fpage>1084</fpage>
<lpage>1091</lpage>
<pub-id pub-id-type="pmid">9545396</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>